{"id":"NCT00148798","sponsor":"Merck KGaA, Darmstadt, Germany","briefTitle":"Study of Cisplatin/Vinorelbine +/- Cetuximab as First-line Treatment of Advanced Non Small Cell Lung Cancer (FLEX)","officialTitle":"Open, Randomized, Controlled, Multicenter Phase III Study Comparing Cisplatin/Vinorelbine Plus Cetuximab Versus Cisplatin/Vinorelbine as First-line Treatment for Patients With Epidermal Growth Factor Receptor Expressing (EGFR-expressing) Advanced NSCLC.","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2004-10","primaryCompletion":"2007-07","completion":"2012-05","firstPosted":"2005-09-08","resultsPosted":"2011-10-04","lastUpdate":"2014-06-25"},"enrollment":1861,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Non Small Cell Lung Cancer (NSCLC)"],"interventions":[{"type":"DRUG","name":"cetuximab + cisplatin + vinorelbine","otherNames":[]},{"type":"DRUG","name":"cisplatin + vinorelbine","otherNames":[]}],"arms":[{"label":"Cetuximab plus chemotherapy","type":"EXPERIMENTAL"},{"label":"Chemotherapy alone","type":"ACTIVE_COMPARATOR"}],"summary":"The purpose of this trial is to investigate the efficacy of cetuximab in combination with chemotherapy in comparison to chemotherapy alone in patients with advanced non small cell lung cancer who did not received prior chemotherapy. Overall survival will be taken as primary measure of efficacy.","primaryOutcome":{"measure":"Overall Survival Time (OS)","timeFrame":"Time from randomisation to death or last day known to be alive, reported between day of first patient randomised, Oct 2004, until cut-off date 18 Jul 2007","effectByArm":[{"arm":"Cetuximab Plus Chemotherapy","deltaMin":11.3,"sd":null},{"arm":"Chemotherapy Alone","deltaMin":10.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0441"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":5},"locations":{"siteCount":118,"countries":["Argentina","Australia","Austria","Belgium","Brazil","Bulgaria","Chile","Czechia","France","Germany","Hong Kong","Hungary","Ireland","Italy","Mexico","Netherlands","Poland","Russia","Singapore","Slovakia","South Korea","Spain","Sweden","Switzerland","Taiwan","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["19410716","22498112","22056021","21782507","21169060"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":325,"n":548},"commonTop":["Neutropenia","Nausea","Anaemia","Vomiting","Anorexia"]}}